UBS Downgrades InterMune To Neutral

Analysts at UBS downgraded InterMune

from Buy to Neutral. The price target for InterMune has been raised from $52.00 to $74.00. InterMune shares have jumped 403.30% over the past 52 weeks, while the S&P 500 index has gained 22.33% in the same period. InterMune shares rose 0.01% to $73.18 at 10:40 a.m. ET.